News

SkyePharma said Requip extended release has been designed to provide a steady rate of absorption in the body to help reduce blood plasma fluctuations over 24 hours. The

The drug is indicated for impertigo caused by susceptible strains of staphylococcus aureus or streptococcus pyogenes, the two most common types of bacteria in this kind of infection,

The study met its primary endpoint of increasing recurrence-free survival. However, there was no difference in overall survival for patients on the two treatment arms. Researchers found that

The committee said it voted against recommending the drug Arcoxia, for the treatment of osteoarthritis, because data suggests the drug is no more effective than similar drugs in

The company previously announced that it had filed an investigational new drug application with the FDA for an oral formulation of picoplatin in February 2007. The phase I

According to these analyses, Mircera corrected and maintained hemoglobin (Hb) levels in patients with chronic kidney disease (CKD). The drug also maintained Hb levels in dialysis patients, regardless

The drug produced disappointing results in one study but in another ongoing a study the data was more encouraging. One study showed that when valopicitabine was combined with

DX-88, an internally discovered, recombinant, plasma kallikrein inhibitor, is in clinical trials for the treatment of acute attacks of hereditary angioedema (HAE), a rare genetic disease characterized by

Schiff Nutrition said sales were $45 million for the third quarter of fiscal 2007, compared to the $49.6 million recorded in the same period in fiscal 2006. Bruce